Skip to main content
Top
Published in: Nutrition & Metabolism 1/2011

Open Access 01-12-2011 | Research

Regulation of blood pressure and glucose metabolism induced by L- tryptophan in stroke-prone spontaneously hypertensive rats

Authors: Syah Ardiansyah, Hitoshi Shirakawa, Yuto Inagawa, Takuya Koseki, Michio Komai

Published in: Nutrition & Metabolism | Issue 1/2011

Login to get access

Abstract

Background

Amino acids have been reported to act as modulators of various regulatory processes and to provide new therapeutic applications for either the prevention or treatment of metabolic disorders. The purpose of the present study is to investigate the effects of single oral dose administration and a continuous treatment of L- tryptophan (L- Trp) on the regulation of blood pressure and glucose metabolism in stroke-prone spontaneously hypertensive rats (SHRSP).

Methods

First, male 9-week-old SHRSP were administered 100 mg L- Trp·kg-1 body weight in saline to the L- Trp group and 0.9% saline to the control group via a gastric tube as a single oral dose of L- Trp. Second, three groups of SHRSP were fed an AIN-93M-based diet supplemented with L- tryptophan (L- Trp) (0, 200, or 1000 mg·kg-1 diet) for 3 weeks as continuous treatment of L- Trp.

Results

Single oral dose administration of L- Trp improved blood pressure, blood glucose, and insulin levels. Blood pressure, blood glucose, and insulin levels improved significantly in the L- Trp treatment groups. The administration of L- Trp also significantly increased plasma nitric oxide and serotonin levels.

Conclusion

L- Trp by both single oral dose administration and continuous treatment improves glucose metabolism and blood pressure in SHRSP.
Appendix
Available only for authorised users
Literature
1.
go back to reference Zimmet P, Alberti KG, Shaw J: Global and societal implications of the diabetes epidemic. Nature. 2001, 414: 782-787. 10.1038/414782a.CrossRef Zimmet P, Alberti KG, Shaw J: Global and societal implications of the diabetes epidemic. Nature. 2001, 414: 782-787. 10.1038/414782a.CrossRef
2.
go back to reference Giugliano D: Dietary antioxidant for cardiovascular prevention. Nutr Metab Cardiovasc Dis. 2000, 20: 38-44. Giugliano D: Dietary antioxidant for cardiovascular prevention. Nutr Metab Cardiovasc Dis. 2000, 20: 38-44.
3.
go back to reference Tuomilehto J, Lindström J: Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med. 2001, 344: 1343-1350. 10.1056/NEJM200105033441801.CrossRef Tuomilehto J, Lindström J: Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med. 2001, 344: 1343-1350. 10.1056/NEJM200105033441801.CrossRef
4.
go back to reference Wolf WA, Kuhn DM: Effect of L-tryptophan on blood pressure in normotensive and hypertensive rats. J Pharmacol Exp Ther. 1984, 230: 324-329. Wolf WA, Kuhn DM: Effect of L-tryptophan on blood pressure in normotensive and hypertensive rats. J Pharmacol Exp Ther. 1984, 230: 324-329.
5.
go back to reference Cook JS, Pogson CI: Tryptophan and glucose metabolism in rat liver cells; The effects of DL-6-chlorotryptophan, 4-chloro-3-hydroxyanthranilate and pyrazinamide. Biochem J. 1983, 214: 511-516.CrossRef Cook JS, Pogson CI: Tryptophan and glucose metabolism in rat liver cells; The effects of DL-6-chlorotryptophan, 4-chloro-3-hydroxyanthranilate and pyrazinamide. Biochem J. 1983, 214: 511-516.CrossRef
6.
go back to reference Watanabe H, Asakasa D, Ogasawara H: Peripheral serotonin enhances lipid metabolism by accelerating bile acid turnover. Endocrinology. 2010, 151: 4776-4786. 10.1210/en.2009-1349.CrossRef Watanabe H, Asakasa D, Ogasawara H: Peripheral serotonin enhances lipid metabolism by accelerating bile acid turnover. Endocrinology. 2010, 151: 4776-4786. 10.1210/en.2009-1349.CrossRef
7.
go back to reference Rapport MM, Green AA, Page IH: Crystalline serotonin. Science. 1948, 108: 329-330. 10.1126/science.108.2804.329.CrossRef Rapport MM, Green AA, Page IH: Crystalline serotonin. Science. 1948, 108: 329-330. 10.1126/science.108.2804.329.CrossRef
8.
go back to reference Holland JM: Serotonin deficiency and prolonged bleeding in beige mice. Proc Soc Exp Biol Med. 1976, 151: 32-39.CrossRef Holland JM: Serotonin deficiency and prolonged bleeding in beige mice. Proc Soc Exp Biol Med. 1976, 151: 32-39.CrossRef
9.
go back to reference Hixson EJ, Lehrmann GV, Maickel RP: Contractile responses to tryptamine analogues in isolated smooth muscle. Arch Int Pharmacodyn Ther. 1977, 229: 4-14. Hixson EJ, Lehrmann GV, Maickel RP: Contractile responses to tryptamine analogues in isolated smooth muscle. Arch Int Pharmacodyn Ther. 1977, 229: 4-14.
10.
go back to reference Yamada J, Sugimoto Y, Kimura I: Serotonin-induced hypoglycemia and increased serum insulin levels in mice. Life Sci. 1989, 45: 1931-1936. 10.1016/0024-3205(89)90547-X.CrossRef Yamada J, Sugimoto Y, Kimura I: Serotonin-induced hypoglycemia and increased serum insulin levels in mice. Life Sci. 1989, 45: 1931-1936. 10.1016/0024-3205(89)90547-X.CrossRef
11.
go back to reference Sugimoto Y, Kimura I, Yamada J: Effects of serotonin on blood glucose and insulin levels of glucose-and streptozotocin-treated mice. Jpn J Pharmacol. 1990, 54: 93-96. 10.1254/jjp.54.93.CrossRef Sugimoto Y, Kimura I, Yamada J: Effects of serotonin on blood glucose and insulin levels of glucose-and streptozotocin-treated mice. Jpn J Pharmacol. 1990, 54: 93-96. 10.1254/jjp.54.93.CrossRef
12.
go back to reference Wozniak KM, Linnoila M: Hyperglycemic properties of serotonin receptor antagonists. Life Sci. 1991, 49: 101-109. 10.1016/0024-3205(91)90023-5.CrossRef Wozniak KM, Linnoila M: Hyperglycemic properties of serotonin receptor antagonists. Life Sci. 1991, 49: 101-109. 10.1016/0024-3205(91)90023-5.CrossRef
13.
go back to reference Furman BL, Wilson GA: Further studies on the effects of 5-hydroxytryptophan on plasma glucose and insulin in the mouse. Diabetologia. 1980, 19: 386-390. 10.1007/BF00280525.CrossRef Furman BL, Wilson GA: Further studies on the effects of 5-hydroxytryptophan on plasma glucose and insulin in the mouse. Diabetologia. 1980, 19: 386-390. 10.1007/BF00280525.CrossRef
14.
go back to reference Aitman TJ, Gotoda T, Evans AL: Quantitative trait loci for cellular defects in glucose and fatty acid metabolism in hypertensive rats. Nat Genet. 1997, 16: 197-201. 10.1038/ng0697-197.CrossRef Aitman TJ, Gotoda T, Evans AL: Quantitative trait loci for cellular defects in glucose and fatty acid metabolism in hypertensive rats. Nat Genet. 1997, 16: 197-201. 10.1038/ng0697-197.CrossRef
15.
go back to reference Collison M, Glazier AM, Graham D: Cd36 and molecular mechanisms of insulin resistance in the stroke-prone spontaneously hypertensive rat. Diabetes. 2000, 49: 2222-2226. 10.2337/diabetes.49.12.2222.CrossRef Collison M, Glazier AM, Graham D: Cd36 and molecular mechanisms of insulin resistance in the stroke-prone spontaneously hypertensive rat. Diabetes. 2000, 49: 2222-2226. 10.2337/diabetes.49.12.2222.CrossRef
16.
go back to reference Ardiansyah , Shirakawa H, Koseki T: Rice bran fractions improve blood pressure, lipid profile, and glucose metabolism in stroke-prone spontaneously hypertensive rats. J Agric Food Chem. 2006, 54: 1914-1920. 10.1021/jf052561l.CrossRef Ardiansyah , Shirakawa H, Koseki T: Rice bran fractions improve blood pressure, lipid profile, and glucose metabolism in stroke-prone spontaneously hypertensive rats. J Agric Food Chem. 2006, 54: 1914-1920. 10.1021/jf052561l.CrossRef
17.
go back to reference Friedewald WT, Levy RI, Fredrickson DS: Estimation of the concentration of low-density lipoprotein cholesterol in plasma without use of the preparative ultracentrifuge. Clin Chem. 1972, 18: 499-502. Friedewald WT, Levy RI, Fredrickson DS: Estimation of the concentration of low-density lipoprotein cholesterol in plasma without use of the preparative ultracentrifuge. Clin Chem. 1972, 18: 499-502.
18.
go back to reference Ardiansyah , Shirakawa H, Koseki T: The Driselase-treated fraction of rice bran is a more effective dietary factor to improve hypertension, glucose and lipid metabolism in stroke-prone spontaneously hypertensive rats compared to ferulic acid. Br J Nutr. 2007, 97: 67-76. 10.1017/S000711450721013X.CrossRef Ardiansyah , Shirakawa H, Koseki T: The Driselase-treated fraction of rice bran is a more effective dietary factor to improve hypertension, glucose and lipid metabolism in stroke-prone spontaneously hypertensive rats compared to ferulic acid. Br J Nutr. 2007, 97: 67-76. 10.1017/S000711450721013X.CrossRef
19.
go back to reference Mattews DR, Hosker JP, Rudenski AS: Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985, 28: 412-419. 10.1007/BF00280883.CrossRef Mattews DR, Hosker JP, Rudenski AS: Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985, 28: 412-419. 10.1007/BF00280883.CrossRef
20.
go back to reference Shirakawa H, Ohsaki Y, Minegishi Y: Vitamin K deficiency reduces testosterone production in the testis through down-regulation of the Cyp11a a cholesterol side chain cleavage enzyme in rats. Biochim Biophys Acta. 2006, 1760: 1482-1488.CrossRef Shirakawa H, Ohsaki Y, Minegishi Y: Vitamin K deficiency reduces testosterone production in the testis through down-regulation of the Cyp11a a cholesterol side chain cleavage enzyme in rats. Biochim Biophys Acta. 2006, 1760: 1482-1488.CrossRef
21.
go back to reference Okamoto K, Yamori Y, Nagaoka A: Establishment of the stroke-prone spontaneously hypertensive rat (SHR). Circ Res. 1974, 34/35: 143-153. Okamoto K, Yamori Y, Nagaoka A: Establishment of the stroke-prone spontaneously hypertensive rat (SHR). Circ Res. 1974, 34/35: 143-153.
22.
go back to reference Miguel M, Alvarez Y, López-Fandiño R: Vasodilator effects of peptides derived from egg white proteins. Regul Pept. 1997, 140: 131-135.CrossRef Miguel M, Alvarez Y, López-Fandiño R: Vasodilator effects of peptides derived from egg white proteins. Regul Pept. 1997, 140: 131-135.CrossRef
23.
go back to reference Matoba N, Usui H, Fujita H: A novel anti-hypertensive peptide derived from ovalbumin induces nitric oxide-mediated vasorelaxation in an isolated SHR mesenteric artery. FEBB Lett. 1999, 452: 181-184. 10.1016/S0014-5793(99)00587-6.CrossRef Matoba N, Usui H, Fujita H: A novel anti-hypertensive peptide derived from ovalbumin induces nitric oxide-mediated vasorelaxation in an isolated SHR mesenteric artery. FEBB Lett. 1999, 452: 181-184. 10.1016/S0014-5793(99)00587-6.CrossRef
24.
go back to reference Hajduch E, Rencurel F, Balendran A: Serotonin (5-hydroxytryptamine), a novel regulator of glucose transport in rat skeletal muscle. J Biol Chem. 1999, 274: 13563-13568. 10.1074/jbc.274.19.13563.CrossRef Hajduch E, Rencurel F, Balendran A: Serotonin (5-hydroxytryptamine), a novel regulator of glucose transport in rat skeletal muscle. J Biol Chem. 1999, 274: 13563-13568. 10.1074/jbc.274.19.13563.CrossRef
25.
go back to reference Chi TC, Ho YJ, Chen WP: Serotonin enhances beta-endorphin secretion to lower plasma glucose in streptozotocin-induced diabetic rats. Life Sci. 2007, 80: 1832-1838. 10.1016/j.lfs.2007.02.016.CrossRef Chi TC, Ho YJ, Chen WP: Serotonin enhances beta-endorphin secretion to lower plasma glucose in streptozotocin-induced diabetic rats. Life Sci. 2007, 80: 1832-1838. 10.1016/j.lfs.2007.02.016.CrossRef
26.
go back to reference Paulmann N, Grohmann M, Voight JP: Intracellular serotonin modulates insulin secretion from pancreatic beta-cells by protein serotonylation. PLoS Biol. 2009, 7 (10): e1000229-10.1371/journal.pbio.1000229.CrossRef Paulmann N, Grohmann M, Voight JP: Intracellular serotonin modulates insulin secretion from pancreatic beta-cells by protein serotonylation. PLoS Biol. 2009, 7 (10): e1000229-10.1371/journal.pbio.1000229.CrossRef
27.
go back to reference Cade JR, Fregly MJ, Privette M: Effect of tryptophan and 5-hydroxytryptophan on the blood pressure of patients with mild to moderate hypertension. Amino Acid. 1992, 2: 133-142. 10.1007/BF00806084.CrossRef Cade JR, Fregly MJ, Privette M: Effect of tryptophan and 5-hydroxytryptophan on the blood pressure of patients with mild to moderate hypertension. Amino Acid. 1992, 2: 133-142. 10.1007/BF00806084.CrossRef
Metadata
Title
Regulation of blood pressure and glucose metabolism induced by L- tryptophan in stroke-prone spontaneously hypertensive rats
Authors
Syah Ardiansyah
Hitoshi Shirakawa
Yuto Inagawa
Takuya Koseki
Michio Komai
Publication date
01-12-2011
Publisher
BioMed Central
Published in
Nutrition & Metabolism / Issue 1/2011
Electronic ISSN: 1743-7075
DOI
https://doi.org/10.1186/1743-7075-8-45

Other articles of this Issue 1/2011

Nutrition & Metabolism 1/2011 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.